4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-032091
See Remarks sold 2,485 shares at an average $3.04 ($7,561)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schwartz Jonathan David See Remarks | 2025-08-18 | Sale | −1,680 | $3.07 | $5,149 | 222,414 | D: show line 1 in the form |
| Schwartz Jonathan David See Remarks | 2025-08-19 | Sale | −805 | $3.00 | $2,412 | 221,609 | D: show line 2 in the form |
| Open-market sales · 2,485 sh · avg $3.04 · $7,561 | |||||||
Loading xslF345X05/form4.xml…